Expanding clinical testing into veterinary medicine
First written in FY2024-Q3. 2 of 4 entries say "Restated". Latest entry: FY2026-H1.
0 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「CPM has entered into a joint research agreement with Osaka Public University Corporation concerning liquid biopsy in veterinary medicine and will collect data aimed at establishing an indicator for monitoring cancer recurrence by periodically sampling cfDNA in the plasma of dogs after cancer treatment. CPM has also entered into a joint research agreement with WOLVES HAND Co., Ltd. concerning the early detection of cancer through liquid biopsy in veterinary medicine, and it has been announced that a clinical study has begun at WOLVES HAND's Veterinary Advanced Medical Research Institute.」
In veterinary medicine, CPM continues its joint research with Osaka Public University Corporation and WOLVES HAND, data collection aimed at an indicator for monitoring recurrence in dogs, and efforts leading to the start of a clinical study. - FY2025RestatedAnnual report
「CPM has entered into a joint research agreement with Osaka Public University Corporation concerning liquid biopsy in veterinary medicine and will collect data aimed at establishing an indicator for monitoring cancer recurrence by periodically sampling cfDNA in the plasma of dogs after cancer treatment.」
In veterinary medicine, CPM continues its joint research with Osaka Public University Corporation and WOLVES HAND, data collection aimed at an indicator for monitoring recurrence in dogs, and efforts leading to the start of a clinical study. - FY2025-H1AdvancedAnnual report
「CPM has entered into a joint research agreement with Osaka Public University Corporation concerning liquid biopsy in veterinary medicine and will collect data aimed at establishing an indicator for monitoring cancer recurrence by periodically sampling cfDNA in the plasma of dogs after cancer treatment. CPM has also entered into a joint research agreement with WOLVES HAND Co., Ltd. concerning the early detection of cancer through liquid biopsy in veterinary medicine, and it has been announced that a clinical study has begun at WOLVES HAND's Veterinary Advanced Medical Research Institute.」
For the expansion of clinical testing into veterinary medicine, joint research agreements with Osaka Public University Corporation and WOLVES HAND have been specified. The initiative has advanced to concrete data collection aimed at an indicator for monitoring recurrence in dogs and the start of a clinical study at the Veterinary Advanced Medical Research Institute. - FY2024-Q3First statedAnnual report
「CPM will leverage the expertise it has accumulated to date, work with research institutions and others in the veterinary medicine field to examine the usefulness of clinical testing, and contribute to veterinary medicine.」
CPM has for the first time indicated a policy of leveraging its accumulated expertise in genomic analysis and other areas to examine the usefulness of clinical testing through collaboration with research institutions and others in the veterinary medicine field.